Extended disease control with unconventional cabozantinib dose increase in metastatic renal cell carcinoma.

Sharma, Akanksha; Elias, Roy; Christie, Alana; Williams, Noelle S; Pedrosa, Ivan; Bjarnason, Georg A; Brugarolas, James.

Afiliação

Sharma A; Department of Internal Medicine, University of Texas Southwestern Medical Center (UTSW), Dallas, TX.
Elias R; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX.
Christie A; These authors contributed equally to this work.
Williams NS; Department of Internal Medicine, University of Texas Southwestern Medical Center (UTSW), Dallas, TX.
Pedrosa I; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX.
Bjarnason GA; These authors contributed equally to this work.
Brugarolas J; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX.

Kidney Cancer ; 6(1): 69-79, 2022.

Article em En | MEDLINE | ID: mdl-36743424